Cargando…
Unilateral Posterior Uveitis in a Patient Receiving Nivolumab for Malignant Melanoma
Patients using immunotherapies like immune checkpoint inhibitors (ICIs) can develop ocular immune-related adverse effects (irAEs). Nivolumab (Opdivo(®);Bristol-Myers Squibb, New York, NY, USA) is a commonly used ICI used to treat malignancies. A 75-year-old woman presented to our eye clinic with sud...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492902/ https://www.ncbi.nlm.nih.gov/pubmed/37700996 http://dx.doi.org/10.7759/cureus.43311 |